Browsing Category
Health
Eisai Biogen: Alzheimer’s drug Leqembi reveals advantages over three years
The newly FDA-approved Alzheimer's drug Leqembi is prepared on Tuesday, November 7, 2023, at Abington Neurological Associates in Abington, PA. Hannah Yoon…
Within the rotation out of know-how shares, an optimistic forecast for main banks is misplaced
Every weekday, CNBC Investing Club with Jim Cramer publishes the Homestretch -- an actionable afternoon update, just in time for the final hour of trading on…
We’re inspired by Abbott’s share buying and selling, however discouraged by Honeywell’s…
Every weekday, CNBC Investing Club with Jim Cramer publishes the Homestretch -- an actionable afternoon update, just in time for the final hour of trading on…
A competitor's poor earnings report is nice information for Abbott Labs
Every weekday, CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. ET. Here's a recap of Friday's key moments.…
Dexcom (DXCM) Q2 earnings report
The Dexcom logo is visible on the smartphone screen and in the background.Pavlo Gonchar | SOPA images | Lightrocket | Getty ImagesShares of Dexcom plunged…
Dexcom shares plunge over 40% after Q2 outcomes
Dexcom Shares fell more than 40% on Friday, their sharpest decline yet, after the diabetes management company reported disappointing second-quarter sales and…
Bristol Myers Squibb (BMY) earnings Q2 2024
Bristol Myers Squibb's research and development center at Cambridge Crossing in Cambridge, Massachusetts, on December 27, 2023.Adam Glanzman | Bloomberg…
Viking Therapeutics shares rise on plans to check weight-loss injections
Concept of a weight loss drug.Cr | Istock | Getty ImagesShares of Viking Therapeutics rose more than 30% on Thursday after the biotechnology company…
Pfizer’s gene remedy in opposition to hemophilia A efficiently in superior testing part
Kena Betancur | Corbis News | Getty ImagesPfizer announced Wednesday that its experimental gene therapy for a rare genetic blood-clotting disorder was…
First spherical of negotiations on Medicare drug costs nears finish
Activists protest against the cost of prescription drugs outside the U.S. Department of Health and Human Services building in Washington, DC on October 6,…